Relevant bibliographies by topics / Drugs in New Zealand

Contents

  1. Journal articles
  2. Dissertations / Theses
  3. Books
  4. Book chapters
  5. Conference papers
  6. Reports

Academic literature on the topic 'Drugs in New Zealand'

Author: Grafiati
Published: 4 June 2021
Last updated: 1 February 2022

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'Drugs in New Zealand.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Journal articles on the topic "Drugs in New Zealand"

1

Menkes, David. "New Zealand drugs row set to continue." Lancet 351, no. 9097 (January 1998): 195. http://dx.doi.org/10.1016/s0140-6736(05)78191-5.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Hill, Amy. "Access to Information and Medicines Regulation in New Zealand." Victoria University of Wellington Law Review 45, no. 4 (December 1, 2014): 549. http://dx.doi.org/10.26686/vuwlr.v45i4.4944.

Full text
Abstract:
This article explores a significant issue in the regulatory regime for medicines in New Zealand and around the world: the deficit of information about medicines available to doctors, patients and independent researchers. In New Zealand, while some generic (off-patent) drugs are manufactured domestically, the major suppliers are large multinational companies. Similarly, clinical trials to establish a drug's effectiveness, safety and quality are predominantly undertaken overseas. Much of the information about safety, efficacy and quality of drugs is held and controlled by pharmaceutical companies and regulators. This article proposes ways in which public access to information about medicines can be improved.
APA, Harvard, Vancouver, ISO, and other styles
3

Sinclair, B. L., D. W. Clark, and M. R. Sears. "Use of anti-asthma drugs in New Zealand." Thorax 42, no. 9 (September 1, 1987): 670–75. http://dx.doi.org/10.1136/thx.42.9.670.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Cumming, J., N. Mays, and J. Daube. "How New Zealand has contained expenditure on drugs." BMJ 340, may18 1 (May 18, 2010): c2441. http://dx.doi.org/10.1136/bmj.c2441.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Coulter, D. M. "Reasons for stopping drugs are monitored in New Zealand." BMJ 313, no. 7059 (September 21, 1996): 756. http://dx.doi.org/10.1136/bmj.313.7059.756.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Burton, B. "New Zealand moves to ban direct advertising of drugs." BMJ 328, no. 7431 (January 10, 2004): 68—c—0. http://dx.doi.org/10.1136/bmj.328.7431.68-c.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Hutton, Fiona. "Kiwis, Clubs and Drugs: Club Cultures in Wellington, New Zealand." Australian & New Zealand Journal of Criminology 43, no. 1 (April 2010): 91–111. http://dx.doi.org/10.1375/acri.43.1.91.

Full text
Abstract:
Illicit drug use within club cultures has been well documented internationally, but research and scholarship about New Zealand club cultures is scarce. This article explores recreational drug use among a sample of 18–48-year-old clubbers in Wellington clubs, New Zealand in 2004–5. The normalisation thesis is used as a basis for analysis with a focus on the issues raised by this thesis. The problematic issues raised by the normalisation thesis and developed in this article were that the processes of normalisation, including current regular drug use and drug-wiseness, varies between locales and between casual, formal or reformed drug users. This reflects both variation in ‘cultural accommodation of the illicit’ and the nature of the diverse population represented.
APA, Harvard, Vancouver, ISO, and other styles
8

Casswell, Sally. "Alcohol and other Recreational Drug Issues in New Zealand." Journal of Drug Issues 22, no. 3 (July 1992): 797–805. http://dx.doi.org/10.1177/002204269202200322.

Full text
Abstract:
In New Zealand as in other industrialised countries the pattern of recreational drug use reflects the pattern of availability, with use of the legal drugs alcohol and tobacco more widespread than that of illegal drugs. These two drugs have been the major focus of political activity during the past decade. In the case of tobacco, major public health advances have been achieved by means of legislative change. In contrast, changes in alcohol legislation have resulted in a liberalisation of alcohol availability, but the public health debate continues at the level of policy implementation. Relatively little public or political attention has been paid to illicit drug use during the past decade, but there are signs that this may change in the near future.
APA, Harvard, Vancouver, ISO, and other styles
9

McCaffrey, Hugh. "A Bitter Pill to Swallow: Portugal's Lessons For Drug Law Reform in New Zealand." Victoria University of Wellington Law Review 40, no. 4 (May 4, 2009): 771. http://dx.doi.org/10.26686/vuwlr.v40i4.5252.

Full text
Abstract:
On 1 July 2001, Portugal decriminalised all drugs, replacing criminal sanctions with administrative ones. Portugal's decriminalisation policy focused on individual possession and use of drugs. It was thought that possession and use would be best dealt with outside of the criminal process. In New Zealand, the Law Commission is revisiting the Misuse of Drugs Act 1975. The author seeks to analyse the first two terms of reference: whether the legislative regime should reflect the principle of harm minimisation underpinning the National Drug Policy; and the most suitable model or models for the control of drugs. This paper examines the principles around the criminalisation of possession and use of drugs. In particular, it examines the experience of Portugal, some eight years after decriminalisation. It is argued that New Zealand should adopt a policy of harm minimisation and that the model Portugal presents ought to be seriously considered as a possibility for New Zealand reform.
APA, Harvard, Vancouver, ISO, and other styles
10

Sheridan, Janie, Sophie Jones, and Trudi Aspden. "Prescription drug misuse: quantifying the experiences of New Zealand GPs." Journal of Primary Health Care 4, no. 2 (2012): 106. http://dx.doi.org/10.1071/hc12106.

Full text
Abstract:
INTRODUCTION: The misuse of prescription drugs for their psychoactive effects is an international problem. To date, there is a paucity of quantitative data on prescription drug misuse (PDM) in New Zealand, especially data investigating the experiences of general practitioners (GPs). AIM: To quantify GPs’ experiences regarding PDM in New Zealand in terms of the extent of the problem, challenges faced, problem drugs, and actions taken by GPs once PDM is suspected. METHOD: A cross-sectional postal survey of a random sample of 300 GPs in New Zealand was undertaken. RESULTS: A 45.7% response rate was achieved. Approximately two-thirds of GPs (65.9%) had diagnosed at least one patient with a PDM problem in the last 12 months. Thirty percent of respondents indicated that they had been faced with at least one challenge in the past 12 months, with ‘verbal threats’ being the most common of these (16.3%). Benzodiazepines and opioids were identified as the most problematic drug classes. The action usually taken by the greatest number of GPs once they suspected PDM was to ‘document it’ (97.9%) followed closely by ‘suggest an alternative drug’ (96.7%) and ‘refrain from prescribing the drug’ (91.9%). DISCUSSION: PDM is an issue for GPs. The findings from this study have highlighted the need for further research into this concerning issue, specifically further quantification of the size of the problem in the New Zealand general population. There is also a need for the development and implementation of interventions to help minimise and better manage PDM in New Zealand. KEYWORDS: Prescription drugs; pharmaceutical; drug abuse; drug misuse; general practitioners; New Zealand; questionnaires; quantitative
APA, Harvard, Vancouver, ISO, and other styles
More sources

Dissertations / Theses on the topic "Drugs in New Zealand"

1

Troncoso, Vergara Carolina. "Drugs and driving in New Zealand : an approach to THC culpability /." The University of Waikato, 2006. http://hdl.handle.net/10289/2477.

Full text
Abstract:
For years statistical analysis has been applied to different areas of the natural and applied sciences to determine the degree of confidence that can be placed in research results. This work is a good example of how statistics can be applied to toxicology to enable conclusions and inferences to be made about important areas of interest such as the drugs and driving situation in New Zealand. Two thousand uninjured drivers (Study 1) who had provided an evidential blood alcohol sample, were also tested for cannabis, methamphetamine, benzodiazepines and morphine to determine the incidence of drug use by drinking drivers. To determine the proportion of drivers killed in car crashes who had used drugs and/or alcohol, two hundred and twenty nine fatally injured drivers (Study 2) were tested for alcohol, cannabis, methamphetamine, morphine, benzodiazepines and neutral and basic medicinal drugs that might have an effect on driving performance. Alcohol, cannabis and their combination were found to be the most prevalent drugs used by drivers. The analytical methodologies used were developed and validated by the Institute of Environmental Science and Research Ltd., where this work was carried out. These techniques involved liquid-liquid and liquid-solid extractions, immunoassays and chromatographic techniques for screening and confirmation assays. The statistical analysis of the results was done under the supervision of the Institute's biostatistician. An approach to cannabis culpability, intended to elucidate the role of this drug in car crashes, was applied to the Study 2 results. The number of samples collected during one year of research was not sufficient to enable statistically robust conclusions to be drawn. Cannabis use is illegal in New Zealand but drugs (different to alcohol) are not regularly tested at the roadside. This work as part of a cross-departmental project titled Drinking and drugged driver control: delineating the problem is expected to support the establishment of strategies designed to reduce the road toll and possibly include the screening of non-alcohol drugs in serious and fatally injured drivers.
APA, Harvard, Vancouver, ISO, and other styles
2

Villers, Trevor. "A thematic analysis of recent PHARMAC new medicines' subsidy decisions." Click here to access this resource online, 2008. http://hdl.handle.net/10292/386.

Full text
Abstract:
PHARMAC, the Pharmaceutical Management Agency, manages the Pharmaceutical Schedule on behalf of the Government. The Agency is tasked with securing the best health outcomes that are reasonably achievable from pharmaceutical treatment and from within the amount of funding provided (§ 47 NZPHD Act, 2000). The Agency reports that it continues to improve New Zealanders’ access to funded medicines. In determining which pharmaceuticals to fund, PHARMAC’s Operating Policies and Procedures (OPPs) state that nine criteria guide its decision- making. The OPPs further state that PHARMAC can apply whatever weight it sees fit to the application of these criteria. I undertook a thematic analysis of 20 cases referred by PHARMAC’s principal medical advisory body, the Pharmacology and Therapeutic Advisory Committee (PTAC), to PHARMAC during the period February 2004 to November 2006 to determine whether these criteria were acknowledged in the official minutes of the respective bodies. PTAC is similarly required to take account of the abiding decision criteria. I also sought to determine whether other factors were apparent in guiding the decisions. There was evidence that PHARMAC consistently applied the decision criteria. PTAC was less assiduous in recording its application. In addition, I found that PHARMAC takes account of factors outside the stated criteria. I noted that PHARMAC takes particular account of the degree to which a decision might be publicly, politically or medically contentious in its decision-making. I also found evidence that consistency with prior decisions is another factor which PHARMAC takes into account, though does not apply routinely. This research indicates that PHARMAC does take account of its abiding decision criteria, applying health needs as well as fiscal criteria, though the weighting given each criterion is nowhere apparent in its official minutes. There remains an opportunity for evaluative research to determine whether fiscal considerations ‘outweigh’ needs considerations in PHARMACs decision-making.
APA, Harvard, Vancouver, ISO, and other styles
3

Hyde, Elizabeth Ann. "Drug use and rurality : a cultural analysis of patterns of use by young people in Britain and New Zealand." Thesis, University of Bristol, 1997. http://hdl.handle.net/1983/d69b1e30-4c10-4565-8a0f-453ea8fa3c87.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Swenson, Victor, and Mattias Ekberg. "Usage of Non-steroidal anti-inflammatory drugs in a sample of New Zealanders with osteoarthritis : A cross-sectional study." Thesis, Umeå universitet, Avdelningen för fysioterapi, 2020. http://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-171613.

Full text
Abstract:
Introduction Oral Non-steroidal anti-inflammatory drugs (NSAID) is an analgesia and is commonly used by people with osteoarthritis (OA). Oral NSAID is currently recommended as the second level of treatment for OA, and could be considered if physical activity, topical NSAID or paracetamol do not supply sufficient pain relief.   Aim To investigate how frequently oral NSAID is used in a sample of New Zealanders with OA and also to investigate the exposure to heightened risk of adverse events while using oral NSAID.   Method A cross-sectional survey was conducted to collect information about the use of oral NSAID by people with self-reported OA. The survey included 75 participants who were over the age of 45 with an average age of 70.6 years.   Results While having OA, 57,3% of the sample reported oral NSAID use. The results also show that 52% of the participants with cardiovascular (CV), gastrointestinal (GI) or renal comorbidities used oral NSAID, and 17,3% of them also combined that NSAID with medication for their comorbidity. Concerning the heightened risks of adverse events, 21% of the participants did acquire the analgesia over the counter (OTC), and 76,6% stated that they were over the age of 65.    Conclusion A majority of the participants in the study with self-reported OA take NSAID as an analgesia. Also, the study shows that NSAID is commonly used among participants with co-morbidity, which is similar to figures presented in previous studies in the area. However, the small sample size limits its generalizability to a larger population.
Introduktion Orala icke-steroida antiinflammatoriska läkemedel (NSAID) är en grupp smärtstillande mediciner som är vanligt använt av personer mer artros. Orala NSAID-preparat rekommenderas idag som en andrahandsbehandling och kan övervägas om fysisk aktivitet, topikala NSAID-preparat eller paracetamol inte ger tillräcklig smärtlindrande effekt.   Syfte Att undersöka hur vanligt användandet av orala NSAID-preparat är i ett stickprov av personer med artros i Nya Zeeland samt att undersöka exponering av orala NSAID-preparat i subgrupper med ökad risk för biverkningar vid användande av orala NSAID-preparat.   Metod En tvärsnittsstudie genomfördes för att samla in information kring användning av orala NSAID-preparat av personer med självrapporterad artros. Studiepopulationen bestod av 75 personer över 45 års ålder med en medelålder på 70,6 år.   Resultat 57,3% av deltagarna använder orala NSAID-preparat som behandling för sin självrapporterad artros. Gällande subgrupper med ökad risk för biverkning av NSAID användning visar studien att 52% av deltagare med kardiovaskulära, gastrointestinala eller njurpåverkade sjukdomar använder orala NSAID-preparat och av dessa kombinerar 17,3% NSAID-preparaten med medicin för sin samsjuklighet. Av deltagarna som uppgav att de använder orala NSAID-preparat erhåller 21% av dessa NSAID-preparaten receptfritt över disk. Av deltagare som var 65 år eller äldre uppgav 76,6% att de använder orala NSAID-preparat för behandling av artros.   Slutsats En majoritet av deltagarna med självrapporterad artros tar orala NSAID-preparat i smärtstillande syfte för sin artros. Studien visar också att NSAID ofta används bland deltagare med samsjuklighet, vilket motsvarar presenterade siffror från tidigare studier inom området. Den lilla stickprovsstorleken begränsar emellertid studiens generaliserbahet gentemot en större population.
APA, Harvard, Vancouver, ISO, and other styles
5

Thom, Katey. "Doing ecstasy in Christchurch: Ecstasy users' experiences in relation to drug regulation strategies in New Zealand." Thesis, University of Canterbury. Sociology, 2004. http://hdl.handle.net/10092/6668.

Full text
Abstract:
This thesis explores the relationship between ecstasy users' experiences in a variety of settings and drug regulation strategies in New Zealand. Fieldwork based, it presents the practices and knowledge utilised by a set of users 'doing ecstasy' in Christchurch. The research aims to both extend the sociological literature on ecstasy consumption and produce an analysis that could contribute to the development of harm reduction strategies in New Zealand. It accomplishes this primarily through interviews in which ten Christchurch users reflect on their experiences with ecstasy. This study is supplemented with participant observation within a number of settings in which ecstasy is consumed and quantitative analysis of forty questionnaires distributed through the social networks of those interviewed. This study contributes to the body of knowledge in the field of sociological drug research and harm reduction policy through its exploration of three themes, production, fluidity and control. I argue that what ecstasy 'does' is neither completely socially constructed nor the direct consequence of the drugs' pharmacology. Instead, I demonstrate that experiences of ecstasy are produced and emerge as an effect of users' employment of specific practices and knowledge. From this perspective, users both 'make' and 'let' the effects of ecstasy occur. Users' practices and knowledge are seen as fluid with respect to time, space, people and place. Finally, users' strategies for controlling and managing their negative experiences of ecstasy are discussed. This thesis demonstrates that users' experiences, practices and knowledges of ecstasy are constantly in flux, and considers the implications of this fluidity for harm reduction policy. Attention is directed towards local practices in specific settings and the relevance of locality and spatiality for drug-related harm. I conclude that harm reduction with respect to ecstasy demands a range of strategies by multiply positioned groups and individual actors. I argue that further detailed qualitative research into users' experiences of ecstasy would be beneficial in the development of harm reduction strategies in New Zealand.
APA, Harvard, Vancouver, ISO, and other styles
6

Hann, Michael. "Working with Faith: Faith-Based Organisations and People who have Drug or Alcohol Issues in Aotearoa New Zealand." Thesis, University of Canterbury. Social and Political Sciences, 2010. http://hdl.handle.net/10092/5517.

Full text
Abstract:
Faith-based organizations contribute significantly to the human services but are relatively neglected in the academic literature. This research aims to address this gap. The field of alcohol and drug use is one in which faith-based organizations have long been involved and in which they claim to have considerable success. Therefore it was chosen as a context within which to research such organizations. The overall purpose is to describe the principal characteristics of faith-based organizations. A questionnaire was used to gather data from fifteen faith-based organizations in Aotearoa New Zealand - from about twenty that were found to provide services in this field. Despite the small sample, the key characteristics of faith-based organizations can be identified. All respondents were ministers or managers of the faith-based organizations. They provide detailed information about various aspects of the organizations. It would be insightful to gather data from clients also, but such analysis is beyond the scope of this thesis. The faith-based organizations are divided into three types: congregations, denominations and independents. The data for all three is presented and discussed in the thesis. Research questions concern mission statements, leadership, staff, clients, services, religiosity, funds, facilities and links with other organizations. In answering these, conclusions can be drawn concerning the purpose of the research – describing the main characteristics of faith-based organizations.
APA, Harvard, Vancouver, ISO, and other styles
7

Green, Valerie Joyce. "Tupulaga Tokelau in New Zealand (the Tokelau younger generation in New Zealand)." Thesis, University of Auckland, 1998. http://wwwlib.umi.com/dissertations/fullcit/9928380.

Full text
Abstract:
Tokelauans initiated a contemporary migration from their relatively remote Pacific atolls to New Zealand around 1960 and this population movement was assisted by government resettlement schemes. The broad objectives of the ethnographic research contributing to this thesis were to study the historical context of this small-scale voluntary migration, the establishment and social organisation of culturally distinguished urban communities in North Island centres, and post-resettlement outcomes experienced by migrant and descent populations. Each of the two studies incorporated in the thesis is primarily concerned with tūpulaga ‘the younger generation’ in the New Zealand Tokelau population. One is community-based and focused on the social interactions of generation cohorts of tūpulaga and tupuna ‘elders’, the formal community associations and the national association of affiliated tūpulaga groups. The other is concerned with bunches of “detached” tūpulaga geographically scattered throughout the country, the people without voices when research includes only the migrants in urban enclaves. Background considerations include overviews of theoretical approaches to studying the population phenomenon of migration; relevant aspects of Tokelau history and the movement of Pacific peoples; New Zealand as the receiving country and continuously changing social context for Tokelau communities, and a conceptual framework derived from features of complex adaptive systems theories that was helpful in considering aspects of the contemporary migration and its outcomes. Tūpulaga leaders, through the association of affiliated groups known as the Mafutaga, revived the pre-eminent cultural principle maopoopo ‘gathered together and unified’, promoted a vision of ‘Tokelau ways in New Zealand’ and supported tūpulaga “becoming Tokelau in New Zealand” as residents of urban communities. Over a number of years, Mafutaga officials led the expansion of tūpulaga inter-community sports meetings into a four-day national gathering of Tokelauans now celebrated as an unequivocal expression of Tokelau culture in New Zealand, and guided the established urban communities through a transition from migrant to cultural communities without usurping the political roles of esteemed elders. The second study shows that intergenerational issues were pivotal or contributory in most tūpulaga decisions to “detach” from community networks and activities. “Detachment” is categorised as transient (a provisional, not necessarily long-term status), tacit (a restorative withdrawal, with subsequent reattachment) or diuternal (a considered choice and enduring status).
Subscription resource available via Digital Dissertations only.
APA, Harvard, Vancouver, ISO, and other styles
8

Nicholson, Heather Halcrow. "The New Zealand Greywackes: A study of geological concepts in New Zealand." Thesis, University of Auckland, 2003. http://hdl.handle.net/2292/90.

Full text
Abstract:
This thesis traces changes in geological concepts associated with the New Zealand greywackes. Since mineralogists adopted the German mining term 'grauwacke' in the 1780s to refer to a type of old, hard, grey, muddy sandstone, both the name and the rock have caused confusion and controversy. English geologists in the 1830s used the term 'grauwacke' as a rock name and a formation name for their most ancient rocks. The English abandoned the name, but 'greywacke' remained useful in Scotland and began to be used in New Zealand in the 1890s. New Zealanders still refer to the association of semi-metamorphosed greywacke sandstones, argillites, minor lavas, cherts and limestone constituting the North Island ranges and the Southern Alps as 'the greywackes'. With the South Island schists, the greywackes make up 27% of the surface of the New Zealand landmass. They supply much of our road metal, but otherwise have little economic importance. Work on these basement rocks has rarely exceeded 10% of geological research in New Zealand.Leading geologists of the nineteenth and early twentieth centuries competed to construct stratigraphical models for New Zealand where the greywackes were usually classified as of Paleozoic age. Controversy was generated by insufficient data, field mistakes, wrong fossil identifications, attachment to ruling theories and the inability of European-based conventional stratigraphical methodologies to deal with these Carboniferous to Jurassic rocks formed in a very different and unsuspected geological environment. After 1945, growth of the universities, increased Geological Survey activity, and the acquisition of more reliable data led to fresh explanatory ideas about geosynclines, turbidity currents, depositional facies, low-grade metamorphism, and structural geology. New interest in the greywackes resulted in the accumulation of additional knowledge about their paleontology, petrography, sedimentology and structure. Much of this geological data is stored in visual materials including maps, photographs, and diagrams and these are essential today for the interpretation and transfer of information.The development of plate tectonic theory and the accompanying terrane concept in the seventies and eighties permitted real progress in understanding the oceanic origin of greywackes within submarine accretionary prisms and their transport to the New Zealand region. In the last half century comparatively little geological controversy about the greywackes has taken place because of the acquisition of quantities of data, technological improvements, and the use of a dependable theory of the Earth's crust. Scientific controversy takes place when data and/or background theory is inadequate.
APA, Harvard, Vancouver, ISO, and other styles
9

Jowitt, Deborah Mary. "The H-bug epidemic the impact of antibiotic-resistant staphylococcal infection on New Zealand society and health 1955-1963 : a thesis presented in partial fulfillment of the requirements for the degree of Masters of Health Science (Midwifery), Auckland University of Technology, 2004." Full thesis. Abstract, 2004.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
10

Murray, Georgina. "New Zealand corporate capitalism." Thesis, University of Auckland, 1989. http://hdl.handle.net/2292/2038.

Full text
Abstract:
This thesis describes the process of concentration and centralisation of the top New Zealand corporate class fraction at three levels - the corporate agent, the corporate agency and the corporate structure. These three different perspectives are seen, first, at the level of the empirical evidence of concentration and centralisation over time, and second, at the level of theoretical explanation and lastly, at the level of the sociology of knowledge, that is, how the theories themselves locate within economic cycles. The two empirical bases of this study are the survey of the top thirty companies directors and the top thirty companies networks of.1966, 1976 and 1986. A centrality analysis used on the latter three data sources, found that at the peak of the longwave (1966) when accumulation was high within the protected New Zealand economy, there were few corporate interlocks, suggesting that centralisation (the destruction of already formed capitals) was not a problem. But by the economic downturn (1986) corporate interlocks had proliferated reflecting the insecure nature of the corporate economy in crisis. The main conclusions drawn from the survey and the centralisation data sources positively corroborate the Marxist thesis that the corporate class fraction (as agents of capitalism) are in a free market economy as much directive as reactive to the state, that banks operate at direct and indirect levels of intervention on this class fraction and that there is some evidence of corporate class cohesion.
APA, Harvard, Vancouver, ISO, and other styles
More sources

Books on the topic "Drugs in New Zealand"

1

Parker, J. E. S. Pharmaceutical patents in New Zealand. Auckland, N.Z: IMS (N.Z.) Ltd., 1991.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
2

Ram, Sanya. New Zealand pharmacy law guidebook. Wellington [N.Z.]: Brookers, 2011.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
3

Pharmacology in nursing: Australia and New Zealand. South Melbourne, Victoria, Australia: Cengage Learning Australia Pty Limited, 2013.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
4

Dunn, Helen. Psychopharmacology: A handbook for New Zealand health professionals. 2nd ed. Porirua, N.Z: Whitireia New Zealand, 2010.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
5

Commission, New Zealand Law. Controlling and regulating drugs: A review of the Misuse of Drugs Act 1975. Wellington, N.Z: Law Commission, 2011.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
6

Yska, Redmer. New Zealand green: The story of marijuana in New Zealand. Auckland, N.Z: D. Bateman, 1990.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
7

Attorney-General, New Zealand. Report of the Attorney-General under the New Zealand Bill of Rights Act 1990 on the Misuse of Drugs (Classification of BZP) Amendment Bill 2007. Wellington, N.Z: House of Representatives, 2007.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
8

Cannabis: New Zealand police drug enforcement. Christchurch, N.Z: Willsonscott Pub. International, 2012.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
9

Danzon, Patricia Munch. Reference pricing of pharmaceuticals for medicare: Evidence from Germany, the Netherlands and New Zealand. Cambridge, MA: National Bureau of Economic Research, 2003.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
10

Yesterday's drums. Wellington, N.Z: Steele Roberts, 2001.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
More sources

Book chapters on the topic "Drugs in New Zealand"

1

Wilkins, Chris, Jitesh Prasad, Karl Parker, Marta Rychert, and Helen Moewaka Barnes. "Recent Trends in Alcohol and Other Drug Use Among Police Detainees in New Zealand, 2010–2015." In Non-medical and illicit use of psychoactive drugs, 161–72. Cham: Springer International Publishing, 2016. http://dx.doi.org/10.1007/7854_2016_471.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Claudino-Sales, Vanda. "New Zealand Subantarctic Islands, New Zealand." In Coastal World Heritage Sites, 443–48. Dordrecht: Springer Netherlands, 2018. http://dx.doi.org/10.1007/978-94-024-1528-5_65.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Taylor, Ann C. M. "New Zealand." In International Handbook of Universities, 689–92. London: Palgrave Macmillan UK, 1993. http://dx.doi.org/10.1007/978-1-349-12912-6_108.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Cumming, Jacqueline. "New Zealand." In Health Systems Improvement Across the Globe, 419–24. London: Taylor & Francis, 2017. http://dx.doi.org/10.1201/9781315586359-62.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Joyce, Hester. "New Zealand." In Women Screenwriters, 194–205. London: Palgrave Macmillan UK, 2015. http://dx.doi.org/10.1057/9781137312372_20.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Wood, Antony. "New Zealand." In Sovereigns and Surrogates, 108–43. London: Palgrave Macmillan UK, 1991. http://dx.doi.org/10.1007/978-1-349-11565-5_5.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Culpan, Ian. "New Zealand." In Olympic Education, 206–21. Abingdon, Oxon ; New York, NY : Routledge is an imprint of the Taylor & Francis Group, an Informa Business, [2017]: Routledge, 2017. http://dx.doi.org/10.4324/9780203131510-20.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Streat, Stephen. "New Zealand." In Three Patients, 55–60. Boston, MA: Springer US, 2002. http://dx.doi.org/10.1007/978-1-4615-0939-4_8.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Jefferies, Rodney L. "New Zealand." In Real Estate Education Throughout the World: Past, Present and Future, 447–61. Boston, MA: Springer US, 2002. http://dx.doi.org/10.1007/978-1-4615-0869-4_35.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Capie, Forrest. "New Zealand." In Directory of Economic Institutions, 243–44. London: Palgrave Macmillan UK, 1990. http://dx.doi.org/10.1007/978-1-349-10218-1_30.

Full text
APA, Harvard, Vancouver, ISO, and other styles

Conference papers on the topic "Drugs in New Zealand"

1

Wiwanto, Siska, Lilies Dwi Sulistyani, Fourier Dzar Eljabbar Latief, Sugeng Supriadi, Bambang Pontjo Priosoeryanto, and Benny Syariefsyah Latief. "The experiment of magnesium ECAP miniplate as alternative biodegradable material (on male white New Zealand rabbits)." In 2ND BIOMEDICAL ENGINEERING’S RECENT PROGRESS IN BIOMATERIALS, DRUGS DEVELOPMENT, AND MEDICAL DEVICES: Proceedings of the International Symposium of Biomedical Engineering (ISBE) 2017. Author(s), 2018. http://dx.doi.org/10.1063/1.5023947.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Birs, Isabela R., Cristina I. Muresan, Silviu Folea, and Ovidiu Prodan. "An experimental nanomedical platform for controller validation on targeted drug delivery." In 2017 Australian and New Zealand Control Conference (ANZCC). IEEE, 2017. http://dx.doi.org/10.1109/anzcc.2017.8298504.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Kuhn, M., T. H. Müller, and W. G. Eisert. "CYCLIC THROMBUS FORMATION IN RABBIT AORTA: A NEW MODEL OF ACUTE ARTERIAL THROMBOSIS." In XIth International Congress on Thrombosis and Haemostasis. Schattauer GmbH, 1987. http://dx.doi.org/10.1055/s-0038-1643174.

Full text
Abstract:
Existing models of arterial thrombosis either require extensive surgical intervention or are limited by the short period of observation. Therefore we developed a new model in rabbits to monitor cyclic flow reductions (CFR) due to thrombus formation in a partially denuded and stenosed aorta.An electromagnetic flowprobe was positioned proximally to a stenosis of the abdominal aorta in anesthetized New Zealand rabbits after limited denudation of the vessel using a hemostat. The aortic blood flow was spontaneously reduced due to formation of thrombi. It returned to the basal level after gently shaking the occluder. The 'free flow' (defined as mean area under the flow curve) as well as the frequency of CFR were monitored. CFR persisted in all control animals for 3 to 4 hours. Prostacyclin at an infusion rate of 100 to 250 ng/kg/min completely abolished CFR in 16 of 20 animals. I.v. application of nitroglycerine (0.7 mg/kg/h) or papaverine (2 mg/kg/h) did not affect CFR. This as well as histology indicates strong involvement of platelet aggregation rather than vasospasm. CFR were also reduced by the following drugs: phosphodiesterase inhibitors (AHP 719, 1 mg/kg/h, i.v.; UDCG 212, 5 ug/kg/min., i.v.), a cyclooxigenase inhibitor (sulphinpyrazone, 30 mg/kg, i.v.) or a thromboxane synthetase inhibitor (dazoxiben, 1 mg/kg, i.v.) as well as an alpha2 antagonist (yohimbine, 1 mg/kg, i.v.). Heparin (800 U/kg, i.v.) reduced CFR suggesting significant contribution of the coagulation system.This new approach opens an avenue to long term observations of antithrombotic therapy in a fairly simple and highly reproducible model.
APA, Harvard, Vancouver, ISO, and other styles
4

Sheehan, S. J., A. B. Latif, S. R. Bibby, R. C. Kester, and S. M. Rajah. "THE RECOVERY OF ENDOTHELIAL CELL AND PLATELET PROSTAGLANDIN SYNTHESES AFTER ADMINISTRATION OF ASPIRIN AND INDOBUFEN." In XIth International Congress on Thrombosis and Haemostasis. Schattauer GmbH, 1987. http://dx.doi.org/10.1055/s-0038-1643389.

Full text
Abstract:
Suppression of endothelial prostacyclin (PGI2) by cyclooxygenase inhibition may contribute to the formation of neointimal hyperplasia. While aspirin (ASA) inhibits platelet function for several days, it returns to normal within 24 hours after indobufen (IDB), a reversible cyclooxygenase inhibitor, suggesting that prostacyclin may recover at an even faster rate. In a randomised, controlled study, recovery of platelet and endothelial cell prostaglandin synthesis was compared in 49 New Zealand white rabbits following indobufen (3.5 mg/kg) or aspirin (5 mg/kg). Prostacyclin in arterial incubates and platelet thromboxane A2 (TXA2) production in serum were measured by radioimmunoassay of their meta-bolities, 6Keto PGF1 and thromboxane B2. Platelet prostaglandin synthesis was also monitored by changes in serum malondiealdehyde (MDA).At one hour, both ASA and IDB significantly inhibited PGI2 (p<0.005). TXA2 (p<0.005), and MDA (p<0.02). After IDB, TXA2 and MDA levels returned to normal by 24 hours while inhibition continued in the ASA group (p<0.01). PGI2 synthesis following IDB recovered at 8 hours against 24 hours in the ASA group. We conclude that while both drugs inhibit platelet and endothelial prostaglandins, the earlier recovery of prostacyclin synthesis following indobufen may allow the endothelium to resume its physiological function.
APA, Harvard, Vancouver, ISO, and other styles
5

Saxton, Peter, Mohamed Hammoud, Samuel Andrews, David Newcombe, Anthony Walton, Seb Stewart, Ricky Te Akau, et al. "P557 ‘Flux NZ’: an online national cohort investigating HIV, STI and drug-related practices among new zealand gay and bisexual men." In Abstracts for the STI & HIV World Congress (Joint Meeting of the 23rd ISSTDR and 20th IUSTI), July 14–17, 2019, Vancouver, Canada. BMJ Publishing Group Ltd, 2019. http://dx.doi.org/10.1136/sextrans-2019-sti.631.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Grundlehner, Gertjan, Chris Castle, Robin K. H. Falconer, and Ray Wood. "Phosphate Mining Offshore New Zealand." In Offshore Technology Conference. Offshore Technology Conference, 2012. http://dx.doi.org/10.4043/23256-ms.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Yu, Se-young, Aniket Mahanti, and Mingwei Gong. "Benchmarking ISPs in New Zealand." In 2016 IEEE 35th International Performance Computing and Communications Conference (IPCCC). IEEE, 2016. http://dx.doi.org/10.1109/pccc.2016.7820618.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Falconer, Robin K. H., Chris Castle, and Campbell J. McKenzie. "Phosphate: Chatham Rise, New Zealand." In OCEANS 2011. IEEE, 2011. http://dx.doi.org/10.23919/oceans.2011.6106986.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

"Firm-level innovation in New Zealand." In 19th International Congress on Modelling and Simulation. Modelling and Simulation Society of Australia and New Zealand (MSSANZ), Inc., 2011. http://dx.doi.org/10.36334/modsim.2011.d3.oxley.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Glare, Travis. "Microbial control: Progress from New Zealand." In 2016 International Congress of Entomology. Entomological Society of America, 2016. http://dx.doi.org/10.1603/ice.2016.95070.

Full text
APA, Harvard, Vancouver, ISO, and other styles

Reports on the topic "Drugs in New Zealand"

1

Novichkova, Tatiana. Political administrative map of New Zealand. Edited by Nikolay Komedchikov, Alexandr Khropov, and Larisa Loginova. Entsiklopediya, December 2013. http://dx.doi.org/10.15356/dm2016-02-12-11.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

S. Abdellatif, Omar, Ali Behbehani, and Mauricio Landin. New Zealand COVID-19 Governmental Response. UN Compliance Research Group, July 2021. http://dx.doi.org/10.52008/nz0501.

Full text
Abstract:
The International Health Regulations (2005) are legally binding on 196 States Parties, Including all WHO Member States. The IHR aims to keep the world informed about public health risks, through committing all signatories to cooperate together in combating any future “illness or medical condition, irrespective of origin or source, that presents or could present significant harm to humans.” Under IHR, countries agreed to strengthen their public health capacities and notify the WHO of any such illness in their populations. The WHO would be the centralized body for all countries facing a health threat, with the power to declare a “public health emergency of international concern,” issue recommendations, and work with countries to tackle a crisis. Although, with the sudden and rapid spread of COVID-19 in the world, many countries varied in implementing the WHO guidelines and health recommendations. While some countries followed the WHO guidelines, others imposed travel restrictions against the WHO’s recommendations. Some refused to share their data with the organization. Others banned the export of medical equipment, even in the face of global shortages. The UN Compliance Research group will focus during the current cycle on analyzing the compliance of the WHO member states to the organizations guidelines during the COVID-19 pandemic.
APA, Harvard, Vancouver, ISO, and other styles
3

Rolfe, Jim. Australia-New Zealand Relations: Allies, Friends, Rivals. Fort Belvoir, VA: Defense Technical Information Center, October 2004. http://dx.doi.org/10.21236/ada627510.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Yamaguchi, N. D., and H. D. Keevill. New Zealand: Asia-Pacific energy series, country report. Office of Scientific and Technical Information (OSTI), March 1992. http://dx.doi.org/10.2172/5483235.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Keating, Timothy J. New Zealand Defense Policy Framework, A Strategic Reappraisal. Fort Belvoir, VA: Defense Technical Information Center, March 2004. http://dx.doi.org/10.21236/ada424308.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Jamieson, Ewan. Friend or Ally? A Question for New Zealand. Fort Belvoir, VA: Defense Technical Information Center, May 1991. http://dx.doi.org/10.21236/ada422100.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Yamaguchi, N. D., and H. D. Keevill. New Zealand Asia-Pacific energy series country report. Office of Scientific and Technical Information (OSTI), March 1992. http://dx.doi.org/10.2172/171319.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Bryant, Larry D., Jack W. Thomas, and Mary M. Rowland. Techniques to construct New Zealand elk-proof fence. Portland, OR: U.S. Department of Agriculture, Forest Service, Pacific Northwest Research Station, 1993. http://dx.doi.org/10.2737/pnw-gtr-313.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Pirihi, Russell G. Core Competencies for the Royal New Zealand Air Force. Fort Belvoir, VA: Defense Technical Information Center, April 1998. http://dx.doi.org/10.21236/ada398697.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Edbrooke, S., M. Arnot, R. Funnell, K. Bland, and B. Field. New Zealand Carbon Dioxide Storage Site Assessment: Phase 1. Cooperative Research Centre for Greenhouse Gas Technologies, July 2009. http://dx.doi.org/10.5341/rpt08-1410.

Full text
APA, Harvard, Vancouver, ISO, and other styles
You might also be interested in the extended bibliographies on the topic 'Drugs in New Zealand' for particular source types:
Journal articles Dissertations / Theses Books
We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!

To the bibliography